(Q28324055)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716088

6 November 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

6 November 2022

author name string

H. Higuchi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716088

6 November 2022

K. Mori

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716088

6 November 2022

A. Kato

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716088

6 November 2022

T. Ohkuma

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716088

6 November 2022

T. Endo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716088

6 November 2022

H. Kaji

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716088

6 November 2022

A. Kaji

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716088

6 November 2022

language of work or name

English

0 references

publication date

1991

1 reference

PubMed

March 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1716088

full work available at URL

6 November 2022

https://api.elsevier.com/content/article/PII:0166354291900672?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

https://api.elsevier.com/content/article/PII:0166354291900672?httpAccept=text/plain

6 November 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

6 November 2022

0 references

15

0 references

issue

3

0 references

page(s)

205-16

0 references

cites work

Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV)

1

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Inhibition of HIV reverse transcriptase by 2',3'-dideoxynucleoside triphosphates

6 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Effect of streptonigrin (NSC-45383) and analogs on oncornavirus replication and DNA polymerase activity

6 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase

6 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Size, score and speed of development of tumors in chickens in response to subcutaneous inoculations with Rous sarcoma virus

6 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Inhibition of reverse transcriptase by limocrocin

6 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents

6 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Role of single-electron reduction potential in inhibition of reverse transcriptase by streptonigrin and sakyomicin A

6 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Screening for inhibitors of avian myeloblastosis virus reverse transcriptase and effect on the replication of AIDS-virus

6 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Inhibitory effect of tannins on reverse transcriptase from RNA tumor virus

6 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

6 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin

6 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Specific Inhibition of Nuclear RNA Polymerase II by α-Amanitin

6 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin

6 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

6 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Biological properties of streptonigrin derivatives. II. Inhibition of reverse transcriptase activity

6 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

6 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

6 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

6 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

6 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Enzyme Inhibition VI: Inhibition of Reverse Transcriptase Activity by Protoberberine Alkaloids and Structure–Activity Relationships

6 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase

6 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Comparison of the effect of Carbovir, AZT, and dideoxynucleoside triphosphates on the activity of human immunodeficiency virus reverse transcriptase and selected human polymerases

6 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Inhibition of HIV-1 RNA-dependent DNA polymerase and cellular DNA polymerases alpha, beta and gamma by phosphonoformic acid and other drugs

6 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

Quantitative structure-activity correlations of rifamycins as inhibitors of viral RNA-directed DNA polymerase and mammalian .alpha. and .beta. DNA polymerases

6 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90067-2

6 November 2022

Identifiers

0 references